vs
Amplitude, Inc.（AMPL）与RHYTHM PHARMACEUTICALS, INC.（RYTM）财务数据对比。点击上方公司名可切换其他公司
Amplitude, Inc.的季度营收约是RHYTHM PHARMACEUTICALS, INC.的1.6倍（$91.4M vs $57.3M），Amplitude, Inc.净利率更高（-19.3% vs -83.0%，领先63.7%），RHYTHM PHARMACEUTICALS, INC.同比增速更快（36.9% vs 17.0%），过去两年RHYTHM PHARMACEUTICALS, INC.的营收复合增速更高（48.5% vs 12.2%）
Amplitude是一家美国企业，专注于研发数字分析软件，能够帮助企业梳理用户行为数据、优化产品决策与数字化运营体验。该公司于2021年9月28日在纳斯达克交易所挂牌上市，股票代码为AMPL。
Rhythm Pharmaceuticals是一家专注于罕见病领域的生物制药企业，主要开发和商业化针对罕见遗传性肥胖症的靶向疗法，覆盖POMC缺陷、LEPR缺陷、巴德-毕德氏综合征等适应症，服务北美、欧洲地区缺少有效治疗方案的患者群体。
AMPL vs RYTM — 直观对比
营收规模更大
AMPL
是对方的1.6倍
$57.3M
营收增速更快
RYTM
高出19.9%
17.0%
净利率更高
AMPL
高出63.7%
-83.0%
两年增速更快
RYTM
近两年复合增速
12.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $91.4M | $57.3M |
| 净利润 | $-17.7M | $-47.5M |
| 毛利率 | 74.6% | 91.6% |
| 营业利润率 | -18.3% | -82.2% |
| 净利率 | -19.3% | -83.0% |
| 营收同比 | 17.0% | 36.9% |
| 净利润同比 | 45.8% | -9.6% |
| 每股收益（稀释后） | $-0.13 | $-0.73 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMPLRYTM
| Q4 25 | $91.4M | $57.3M | ||
| Q3 25 | $88.6M | $51.3M | ||
| Q2 25 | $83.3M | $48.5M | ||
| Q1 25 | $80.0M | $32.7M | ||
| Q4 24 | $78.1M | $41.8M | ||
| Q3 24 | $75.2M | $33.3M | ||
| Q2 24 | $73.3M | $29.1M | ||
| Q1 24 | $72.6M | $26.0M |
净利润AMPLRYTM
| Q4 25 | $-17.7M | $-47.5M | ||
| Q3 25 | $-24.0M | $-52.9M | ||
| Q2 25 | $-24.7M | $-46.6M | ||
| Q1 25 | $-22.2M | $-49.5M | ||
| Q4 24 | $-32.6M | $-43.3M | ||
| Q3 24 | $-16.9M | $-43.6M | ||
| Q2 24 | $-23.4M | $-32.3M | ||
| Q1 24 | $-21.5M | $-141.4M |
毛利率AMPLRYTM
| Q4 25 | 74.6% | 91.6% | ||
| Q3 25 | 73.9% | 89.3% | ||
| Q2 25 | 72.6% | 88.6% | ||
| Q1 25 | 74.7% | 88.8% | ||
| Q4 24 | 74.7% | 90.9% | ||
| Q3 24 | 75.1% | 88.5% | ||
| Q2 24 | 73.4% | 89.9% | ||
| Q1 24 | 74.0% | 89.2% |
营业利润率AMPLRYTM
| Q4 25 | -18.3% | -82.2% | ||
| Q3 25 | -26.0% | -102.6% | ||
| Q2 25 | -29.0% | -93.4% | ||
| Q1 25 | -26.8% | -143.7% | ||
| Q4 24 | -41.2% | -98.6% | ||
| Q3 24 | -21.4% | -132.0% | ||
| Q2 24 | -31.7% | -139.2% | ||
| Q1 24 | -29.0% | -538.7% |
净利率AMPLRYTM
| Q4 25 | -19.3% | -83.0% | ||
| Q3 25 | -27.1% | -103.1% | ||
| Q2 25 | -29.6% | -96.1% | ||
| Q1 25 | -27.8% | -151.4% | ||
| Q4 24 | -41.7% | -103.6% | ||
| Q3 24 | -22.4% | -131.2% | ||
| Q2 24 | -31.9% | -110.9% | ||
| Q1 24 | -29.5% | -544.4% |
每股收益（稀释后）AMPLRYTM
| Q4 25 | $-0.13 | $-0.73 | ||
| Q3 25 | $-0.18 | $-0.82 | ||
| Q2 25 | $-0.19 | $-0.75 | ||
| Q1 25 | $-0.17 | $-0.81 | ||
| Q4 24 | $-0.25 | $-0.71 | ||
| Q3 24 | $-0.14 | $-0.73 | ||
| Q2 24 | $-0.19 | $-0.55 | ||
| Q1 24 | $-0.18 | $-2.35 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $192.0M | $388.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $245.3M | $139.1M |
| 总资产 | $420.7M | $480.2M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AMPLRYTM
| Q4 25 | $192.0M | $388.9M | ||
| Q3 25 | $189.2M | $416.1M | ||
| Q2 25 | $208.1M | $291.0M | ||
| Q1 25 | $209.0M | $314.5M | ||
| Q4 24 | $241.1M | $320.6M | ||
| Q3 24 | $319.9M | $298.4M | ||
| Q2 24 | $318.3M | $319.1M | ||
| Q1 24 | $316.1M | $201.2M |
股东权益AMPLRYTM
| Q4 25 | $245.3M | $139.1M | ||
| Q3 25 | $262.2M | $148.8M | ||
| Q2 25 | $279.5M | $-11.9M | ||
| Q1 25 | $289.5M | $18.9M | ||
| Q4 24 | $296.6M | $21.7M | ||
| Q3 24 | $290.0M | $11.2M | ||
| Q2 24 | $287.3M | $39.3M | ||
| Q1 24 | $289.2M | $61.6M |
总资产AMPLRYTM
| Q4 25 | $420.7M | $480.2M | ||
| Q3 25 | $438.1M | $506.9M | ||
| Q2 25 | $456.6M | $372.7M | ||
| Q1 25 | $445.8M | $386.7M | ||
| Q4 24 | $445.9M | $392.3M | ||
| Q3 24 | $445.6M | $363.6M | ||
| Q2 24 | $445.4M | $381.8M | ||
| Q1 24 | $437.9M | $258.7M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $12.8M | $-25.4M |
| 自由现金流经营现金流 - 资本支出 | $12.7M | — |
| 自由现金流率自由现金流/营收 | 13.8% | — |
| 资本支出强度资本支出/营收 | 0.2% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $28.2M | — |
8季度趋势，按日历期对齐
经营现金流AMPLRYTM
| Q4 25 | $12.8M | $-25.4M | ||
| Q3 25 | $5.0M | $-26.6M | ||
| Q2 25 | $20.1M | $-23.3M | ||
| Q1 25 | $-8.0M | $-40.4M | ||
| Q4 24 | $3.2M | $-18.8M | ||
| Q3 24 | $6.2M | $-25.2M | ||
| Q2 24 | $9.2M | $-29.1M | ||
| Q1 24 | $-48.0K | $-40.7M |
自由现金流AMPLRYTM
| Q4 25 | $12.7M | — | ||
| Q3 25 | $4.5M | — | ||
| Q2 25 | $19.5M | — | ||
| Q1 25 | $-8.5M | — | ||
| Q4 24 | $2.4M | — | ||
| Q3 24 | $6.2M | — | ||
| Q2 24 | $8.6M | — | ||
| Q1 24 | $-405.0K | — |
自由现金流率AMPLRYTM
| Q4 25 | 13.8% | — | ||
| Q3 25 | 5.1% | — | ||
| Q2 25 | 23.4% | — | ||
| Q1 25 | -10.6% | — | ||
| Q4 24 | 3.1% | — | ||
| Q3 24 | 8.2% | — | ||
| Q2 24 | 11.8% | — | ||
| Q1 24 | -0.6% | — |
资本支出强度AMPLRYTM
| Q4 25 | 0.2% | — | ||
| Q3 25 | 0.5% | — | ||
| Q2 25 | 0.6% | — | ||
| Q1 25 | 0.5% | — | ||
| Q4 24 | 1.0% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.8% | — | ||
| Q1 24 | 0.5% | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMPL
| US | $55.8M | 61% |
| International | $35.7M | 39% |
RYTM
暂无分部数据
